Epignostix

Visit website

overall

19,373

out of 62,957

-779

traffic

17,902

out of 62,957

-172

investment

4,188

out of 62,957

-2

review

Not Available

These rankings are based on data from May 2026

Company

Heidelberg Epignostix GmbH

Years in business

Number of employees

1-10 employees

Country

Germany

Heidelberg Epignostix leverages DNA methylation and machine learning to enhance cancer diagnostics, enabling precise tumor classification. Established in 2022, it focuses on transforming cancer care with innovative molecular diagnostics solutions.

API Availability

Pricing

unknown

Use

ai cancer detection

ai disease diagnosis

Position of Epignostix on sub rankings

May 2026

AI cancer detection - Overall

20 out of 31

AI disease diagnosis - Overall

94 out of 159

Germany - Overall

947 out of 1,876

AI cancer detection - Overall

20 out of 31

AI disease diagnosis - Overall

94 out of 159

Germany - Overall

947 out of 1,876

Industries

health & sports

research & development

Company

Heidelberg Epignostix GmbH

Years in business

Number of employees

1-10 employees

Country

Germany

Help us improve this profile

Insights

15 new AI Tool Categories... and what each one actually covers

The AI landscape is not easy to file into neat categories. Data cleaning here, sales analysis there, access control in its own box. This is a guide to 15 new categories we rank: what each one actually means and where the label hides more than it shows.

5 New AI Tools: From hiring to healthcare billing

Where the last batch helped teams decide, this one runs the operational layer underneath: the unglamorous back-office work that keeps a business moving.